Free Trial

Milestone Pharmaceuticals (MIST) Insider Trading & Ownership

Milestone Pharmaceuticals logo
$1.93 +0.01 (+0.73%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$1.92 -0.01 (-0.72%)
As of 07/3/2025 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Milestone Pharmaceuticals (NASDAQ:MIST) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
19.50%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$13.71M
Number Of
Insiders Selling
(Last 3 Years)
0
Get MIST Insider Trade Alerts

Want to know when executives and insiders are buying or selling Milestone Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MIST Insider Buying and Selling by Quarter

Milestone Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/5/2022David BharuchaInsiderBuy7,000$4.69$32,830.00  
12/1/2022David BharuchaInsiderBuy3,000$4.86$14,580.00  
10/21/2022Debra K LiebertDirectorBuy4,000$5.26$21,040.00  
10/19/2022Robert James WillsDirectorBuy15,000$4.93$73,950.00  
9/7/2022Rtw Investments, LpMajor ShareholderBuy1,557,346$8.71$13,564,483.66  
(Data available from 1/1/2013 forward)

MIST Insider Trading Activity - Frequently Asked Questions

The list of insiders at Milestone Pharmaceuticals includes David Bharucha, Debra K Liebert, Robert James Wills, and Rtw Investments, Lp. Learn more on insiders at MIST.

19.50% of Milestone Pharmaceuticals stock is owned by insiders. Learn more on MIST's insider holdings.



This page (NASDAQ:MIST) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners